Infectious Diseases

IITRI has more than 40 years of experience in the preclinical development of novel therapeutics and vaccines to protect against infectious diseases. Our services include efficacy and potency evaluations, toxicology and safety assessments, as well as analysis of human clinical trial samples.

Our laboratory and vivarium space contains Biosafety Level 2 and 3 facilities, fully functional with the latest equipment to conduct pathogenic agent studies. We have an extensive collection of animal models, including in vivo models of bioaerosol exposure, and will work collaboratively with sponsors to design and develop custom animal models.

Infectious Diseases Expertise

  • A highly experienced team of scientists from a broad range of disciplines including virology, bacteriology, immunology and molecular biology
  • Development of animal models of infectious disease for use in challenge studies
  • A proprietary bioaerosol program that allows for the efficient, scalable and accurate delivery of pathogens including select agents
  • Specialized expertise in influenza
  • Experience developing GLP-compliant testing programs that meet Animal Rule requirements

Preclinical Toxicology and Safety

  • Our toxicology team is one of the most experienced in the industry
  • Study directors hold both a PhD and DABT
  • Each technician has greater than 10 years of experience in preclinical toxicology
  • Extensive experience evaluating safety of vaccines and therapeutics

The IITRI Advantage

  • A highly experienced team of bacteriologists, virologists, immunologists and molecular biologists
  • ABSL 2/3 laboratories for in vivo efficacy studies of infectious disease pathogens
  • A large pathogen library that includes bacteria, viruses, fungi, toxins and select agents
  • On-site bioanalytical laboratory for prompt analysis of preclinical samples
  • Flexible, collaborative approach to study design to optimize cost and quality

Related Services